secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001746473-24-000084
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics say-on-pay vote fails; Krognes appointed to board
---------------------------------------------------------------------

- Non-binding say-on-pay vote failed: 23,479,353 for, 28,329,655 against, 10,277 abstain.
- Steve Krognes appointed as Class III director and Audit Committee chair; receives option for 53,528 shares vesting over 3 years.
- Board size increased from 10 to 11 members to accommodate Krognes.
- Deloitte & Touche LLP ratified as auditor for FY2024: 56,628,368 for, 10,853 against, 62,998 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/0001746473-24-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000174647324000084/plrx-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001746473-24-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer